
Trihal Pharma Private Limited
About Trihal Pharma Private Limited
Data last updated:
Trihal Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 April 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24290MH2021PTC359068. Its GSTIN is 27AAICT5691H1ZU (Maharashtra).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Trihale Pharma Private Limited. It is led by directors including Manish Mangilal Shah and Amit Bansal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 21 A 2nd Flr Vasudev Chamber Nr. Andheri Subway Old Nagardas X Road Andheri East, Mumbai, Maharashtra, India – 400069.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.36 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹9.14 Cr (net margin -209.8%) and EBITDA of -₹3.83 Cr (EBITDA margin -87.8%).
Its group structure includes 1 subsidiary.
Company details
Contact details
Trihal Pharma Private Limited's registered office is in Mumbai, Maharashtra. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address21 A 2nd Flr Vasudev Chamber Nr. Andheri Subway Old Nagardas X Road Andheri East, Mumbai, Maharashtra, India – 400069
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Trihal Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Trihal Pharma is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Trihal Pharma Private Limited, buy the company report.
Financials of Trihal Pharma Private Limited
FY 2025 filings availableTrihal Pharma Private Limited reported revenue of ₹4.36 Cr (up 828% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 828% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | -₹3.83 Cr | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹9.14 Cr | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | -87.8% | |||
| Net Profit Margin | -209.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Trihal Pharma Private Limited, buy the company report.
Board of directors of Trihal Pharma Private Limited
Trihal Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Manish Mangilal Shah Also directs: Indira Consultancy LLP, Oc Bioscience Private Limited, Oc Specialities Private Limited and 4 more | Director | 01 Feb 2022 | 4 Years 9 Months | Current |
| Amit Bansal | Director | 01 Feb 2022 | 4 Years 9 Months | Current |
| Shekhar Shrawankumar Bhuwania Also directs: Oc Bioscience Private Limited, Respipure Pharma Private Limited, Growlease Fintech I LLP and 5 more | Director | 16 Apr 2021 | 5 Years 7 Months | Current |
Auditor
Trihal Pharma Private Limited is audited by Vanita Bhuva & Co for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Vanita Bhuva & Co | FY 2023 | 145476W |
Shareholding
The shareholding of Trihal Pharma Private Limited is on record for FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Trihal Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Trihal Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Trihal Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Trihal Pharma has 1 subsidiary company. This group structure data is as of FY 2022. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Respipure Pharma Private Limited | U24290MH2022PTC375528 |
To see the full group structure of Trihal Pharma Private Limited, buy the company report.
GST
Trihal Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICT5691H1ZU | Maharashtra | Active | 04 Nov 2021 |
To see the full GST registrations and return filing status of Trihal Pharma Private Limited, buy the company report.
Recent activity
Trihal Pharma Private Limited has 11 board changes on record since 2021: 7 appointments and 4 cessations. The latest: Madhur Vinodkumar Gupta ceased to be Director on 16 Dec 2024.
2 earlier events are in the company report.
Frequently asked questions
Trihal Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 April 2021 (5+ years old) and is registered under CIN U24290MH2021PTC359068.
Trihal Pharma has 3 current directors:
- Manish Mangilal Shah - Director
- Amit Bansal - Director
- Shekhar Shrawankumar Bhuwania - Director
The latest financial statements of Trihal Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Trihal Pharma is 27AAICT5691H1ZU, registered in Maharashtra.
The CIN (Corporate Identification Number) of Trihal Pharma is U24290MH2021PTC359068. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Trihal Pharma was incorporated on 16 April 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Madhur Vinodkumar Gupta ceased to be Director on 16 Dec 2024. Nitin Ganpati Kulkarni ceased to be Additional Director on 31 May 2024. Nishant Vaish ceased to be Additional Director on 24 Jun 2022. Trihal Pharma has 11 board changes on record in total.
The registered office of Trihal Pharma is at 21 A 2nd Flr Vasudev Chamber Nr. Andheri Subway Old Nagardas X Road Andheri East, Mumbai, Maharashtra, India – 400069.
Trihal Pharma operates in the pharma industry, in the drug formulation and development segment.
Trihal Pharma has 1 subsidiary company including Respipure Pharma Private Limited.

